Applications for sulindac in preparing anti-lung cancer products
AssigneeShanghai Jiao Tong University
InventorsYongyong SHI, Zhijian SONG
Life of this patent
Estimating the term…
Abstract
This invention discloses uses for sulindac in preparing anti-lung cancer products. This invention provides uses for sulindac in the preparation of products to treat lung cancer. From carrying out cancer drug repositioning for the FDA- and CFDA-approved drug sulindac, experiments for this invention show, based on screening of non-anti-cancer drugs for various cancer cell lines (tissue types) and mutation sites, that sulindac has a new use as an anti-lung cancer medication, thus achieving a new purpose for an old drug.
Claims4
1-9. (canceled)
A method of inhibiting the proliferation of lung cancer cells comprising contacting the cells with an effective amount of sulindac, thereby inhibiting the proliferation of lung cancer cells.
Dependencies are inferred from the claim text.